Table 3.
Dimensions | Drug Delivery Carriers | Hydrophobic-Drug Models | Drug Release Behaviors | Drug Release Mechanism |
References |
---|---|---|---|---|---|
1D | CNCs–cetyltrimethylammonium bromide suspensions |
Paclitaxel, docetaxel, and etoposide |
A total of 75% of the drug was released over 4 days. | - | [159] |
CNCs/rarasaponin particles |
Tetracycline | More drugs released from neutral condition than in acid condition. |
Pseudo-first-order | [160] | |
2D | BC/hyaluronic acid/ diclofenac films |
Diclofenac sodium |
The maximum cumulative release was 90% which was obtained after 4 min in simulated salivary fluid. |
Non-Fickian transport |
[161] |
CNFs/poly(glycerol sebacate)/polypyrrole patches |
Curcumin | The cumulative drug-released amount was less than 2% with five months in PBS under pH of 7.4. | - | [162] | |
BC/polyvinyl alcohol films | Vanillin | The diffusion process reached equilibrium after 1 h in water. |
Fickian diffusion |
[163] | |
3D | BC/sodium alginate hybrid hydrogels | Ibuprofen | During the first 2 h, the drug release amount was less than 10% in acidic conditions with the pH condition of 1.5. |
Non-Fickian diffusion |
[164] |
Polyethylenimine/BC aerogels | Aspirin | The cumulative drug release was 80.6% with 25 h in pH condition of 7.5. | - | [128] | |
Zeolitic imidazolate framework-8@PCNFs composite hydrogel | Curcumin | Under pH condition of 2.5, the maximum curcumin release amount was 90%. |
Anomalous transport |
[165] |